This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The trade group, however, insisted the FDA “acted to benefit special interests, raise drugprices and deprive much of the public of access to a needed medicine.” A group of doctors and medical practices claimed they overpaid for the vaccine, which was the only mumps shot in the U.S. ” A U.S.
Regulatory pressures, lengthy drug development times, and the fact that drugprices have become politicised have raised risks and cut revenue projections, leading to the biotech sector falling out of fashion. Moreover, the range of companies benefiting from investor interest has not been limited to those developing a vaccine.
These therapies have incredible potential to fight cancer and other diseases using the patient’s own immune system. Some will simply raise drugprices to get more money out of new drugs while they can; others are planning to phase in new indications in order to “reset the clock” as many times as they can.
Absent from the statute is any requirement to report information on manufacturer costs and price setting. Nevertheless, riding on the wave of drugprice transparency legislation in several states and similar legislative proposals in Congress, CMS is proposing to expand the MDRP into the realm of drugprice transparency reporting.
have on vaccines in the U.S.? ’s vaccine views could shape policy President-elect Trump’s decision to entrust noted vaccine skeptic Robert F. One of particular import: What impact will his relationship with Robert F. Kennedy Jr. We have a look at that question today, discuss another U.S. How RFK Jr.’s
This expansion continues a flawed policy that threatens innovation and jeopardizes patient access to critical treatments, including drugs vital for cancer treatment and popular new weight loss medications that have transformed the management of obesity and related conditions. What Will 2025 Mean for Medicare DrugPrice Setting Under the IRA?
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content